Sotac Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	22	15.64	34.18	96.82	0.28	2.69
Short-Term Investments	-	4.59	4.33	4.12	-	1.68
Cash & Short-Term Investments	22	20.23	38.51	100.94	0.28	4.37
Cash Growth	322.12%	-47.47%	-61.85%	36470.65%	-93.68%	-25.36%
Accounts Receivable	327.44	341.12	262.88	147.41	122.53	58.85
Other Receivables	-	0.02	-	3.22	0.55	6.58
Receivables	327.44	341.14	262.88	150.63	123.08	65.43
Inventory	192.36	202.61	180.1	136.42	53.95	48.29
Prepaid Expenses	-	2.15	1.39	0.55	0.11	0.07
Other Current Assets	163.71	132.14	123.58	82.85	81.35	55.33
Total Current Assets	705.51	698.27	606.45	471.39	258.76	173.49
Property, Plant & Equipment	462.2	469.71	387.19	240.5	87.94	165.58
Long-Term Investments	26.77	37.82	20.96	-	3.92	1.29
Goodwill	19.03	19.03	19.01	19.06	-	-
Other Intangible Assets	0.16	0.19	0.13	0.03	0.05	0.01
Long-Term Deferred Tax Assets	13.78	13.01	14.27	-	0.2	-
Other Long-Term Assets	5.25	5.25	5.25	5.25	1.66	6.6
Total Assets	1,233	1,243	1,053	736.39	352.54	346.98
Accounts Payable	207.88	189.44	288.94	253.94	197.42	130.17
Accrued Expenses	-	8.2	6.5	9.63	4.42	3.74
Short-Term Debt	288.34	187.51	98.75	108.24	51.86	65.47
Current Portion of Long-Term Debt	-	107.54	28.53	34.46	12.31	13.03
Current Income Taxes Payable	-	9.14	3.97	15.95	-	-
Other Current Liabilities	30.79	13.65	10.61	35.91	10.05	15.23
Total Current Liabilities	527.01	515.49	437.3	458.12	276.05	227.63
Long-Term Debt	94.09	141.94	121.31	77.69	9.7	92.79
Pension & Post-Retirement Benefits	1.65	1.63	1.37	0.96	0.56	0.39
Long-Term Deferred Tax Liabilities	-	-	-	2.77	-	0.49
Other Long-Term Liabilities	-	-	-	-	-	-0
Total Liabilities	622.75	659.06	559.98	539.54	286.32	321.3
Common Stock	110.5	110.5	110.5	80.5	23	23
Additional Paid-In Capital	-	280.23	280.22	-	-	-
Retained Earnings	-	139.07	58.81	16	-	-
Comprehensive Income & Other	446.31	2.73	3.06	98.1	43.22	1.94
Total Common Equity	556.81	532.52	452.59	194.59	66.22	24.94
Minority Interest	53.14	51.7	40.7	2.26	-	0.74
Shareholders' Equity	609.95	584.22	493.29	196.86	66.22	25.68
Total Liabilities & Equity	1,233	1,243	1,053	736.39	352.54	346.98
Total Debt	382.43	436.99	248.59	220.39	73.88	171.28
Net Cash (Debt)	-360.43	-416.76	-210.08	-119.45	-73.6	-166.91
Net Cash Per Share	-32.60	-37.72	-19.14	-14.84	-9.14	-20.73
Filing Date Shares Outstanding	11.07	11.05	11.05	8.05	8.05	8.05
Total Common Shares Outstanding	11.07	11.05	11.05	8.05	8.05	8.05
Working Capital	178.51	182.78	169.15	13.27	-17.29	-54.13
Book Value Per Share	50.31	48.19	40.96	24.17	8.23	3.10
Tangible Book Value	537.62	513.3	433.45	175.5	66.17	24.93
Tangible Book Value Per Share	48.58	46.45	39.23	21.80	8.22	3.10
Land	-	87.41	87.41	39.22	11.92	25.05
Buildings	-	165.42	89.61	82.7	30.2	32.71
Machinery	-	353.72	259.72	188.01	93.24	162.07
Construction In Progress	-	2.04	51.24	0.41	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.